Meta-Analysis Comparing Metolazone Versus Intravenous Chlorothiazide in Patients With Acute Decompensated Heart Failure

Abstract

Get full access to this article

View all access options for this article.

References

Bohn

Hadgu

Pope

Shuster

JE.

Oral metolazone versus intravenous chlorothiazide as an adjunct to loop diuretics for diuresis in acute decompensated heart failure with reduced ejection fraction. Hosp Pharm. 2019;54(6):351-357. doi:10.1177/0018578718795855

Cisowska

Pan

Biskupiak

Shah

Fang

Jacobs

JA.

Metolazone versus intravenous chlorothiazide for decompensated heart failure sequential nephron blockade: a retrospective cohort study. J Card Fail. 2022;28(8):1367-1371. doi:10.1016/j.cardfail.2022.05.011

Moranville

Choi

Hogg

Anderson

Rich

JD.

Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. Cardiovasc Ther. 2015;33(2):42-49. doi:10.1111/1755-5922.12109

Shulenberger

Jiang

Devabhakthuni

Ivaturi

Liu

Reed

BN.

Efficacy and safety of intravenous chlorothiazide versus oral metolazone in patients with acute decompensated heart failure and loop diuretic resistance. Pharmacotherapy. 2016;36(8):852-860. doi:10.1002/phar.1798

Gibson

Beard

Escano

, et al Metolazone versus chlorothiazide in acute heart failure patients with diuretic resistance and renal dysfunction: a retrospective cohort study. J Cardiovasc Pharmacol. 2024;84:451-456. doi:10.1097/FJC.0000000000001623

Cox

Hung

Lenihan

Testani

JM.

Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T trial. JACC Heart Fail. 2020;8(3):157-168. doi:10.1016/j.jchf.2019.09.012

Steuber

Janzen

Howard

ML.

A systematic review and meta-analysis of metolazone compared to chlorothiazide for treatment of acute decompensated heart failure. Pharmacotherapy. 2020;40(9):924-935. doi:10.1002/phar.2440